PT1212119E - Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas - Google Patents
Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinasInfo
- Publication number
- PT1212119E PT1212119E PT00956565T PT00956565T PT1212119E PT 1212119 E PT1212119 E PT 1212119E PT 00956565 T PT00956565 T PT 00956565T PT 00956565 T PT00956565 T PT 00956565T PT 1212119 E PT1212119 E PT 1212119E
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- ciamemazine
- benzodiazepines
- submitted
- wear
- Prior art date
Links
- 229940049706 benzodiazepine Drugs 0.000 title abstract 2
- 150000001557 benzodiazepines Chemical class 0.000 title 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9910472A FR2797399B1 (fr) | 1999-08-13 | 1999-08-13 | Utilisation de la cyamemazine dans le traitement du sevrage aux benzodiazepines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1212119E true PT1212119E (pt) | 2004-07-30 |
Family
ID=9549128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00956565T PT1212119E (pt) | 1999-08-13 | 2000-07-28 | Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6534500B2 (pt) |
| EP (1) | EP1212119B1 (pt) |
| JP (1) | JP5078209B2 (pt) |
| AT (1) | ATE262362T1 (pt) |
| AU (1) | AU6846300A (pt) |
| CA (1) | CA2381354C (pt) |
| DE (1) | DE60009315T2 (pt) |
| DK (1) | DK1212119T3 (pt) |
| ES (1) | ES2214305T3 (pt) |
| FR (1) | FR2797399B1 (pt) |
| PT (1) | PT1212119E (pt) |
| WO (1) | WO2001012265A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1626727B1 (en) * | 2003-02-07 | 2008-12-31 | Aventis Pharmaceuticals Inc. | Use of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt thereof as a medicament |
| FR2850871B1 (fr) * | 2003-02-07 | 2006-07-14 | Aventis Pharma Sa | Application du 2-cyano-10-(2-methyl-3-(methylamino)propyl) phenothiazine ou un sel pharmaceutiquement acceptable comme medicament |
| US7855196B2 (en) * | 2005-08-22 | 2010-12-21 | Pierre Mainville | Composition comprising a benzodiazepine agonist and a benzodiazepine antagonist |
| DE102011078999A1 (de) | 2011-07-12 | 2013-01-17 | Carl Zeiss Sms Gmbh | Verfahren und Vorrichtung zur Positionsbestimmung von Strukturen auf einer Maske für die Mikrolithographie |
| DE102013101445B9 (de) | 2013-02-14 | 2022-01-05 | Carl Zeiss Smt Gmbh | Verfahren zur Ermittlung von Verzeichnungseigenschaften eines optischen Systems in einer Messvorrichtung für die Mikrolithographie |
| DE102013106320B9 (de) | 2013-06-18 | 2021-07-01 | Carl Zeiss Smt Gmbh | Verfahren zur Ermittlung von Verzeichnungseigenschaften eines optischen Systems in einer Messvorrichtung für die Mikrolithographie |
| DE102013107976B4 (de) | 2013-07-25 | 2016-07-28 | Carl Zeiss Sms Gmbh | Positionsbestimmung von Strukturen auf einer Maske für die Mikrolithographie |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE552557A (pt) * | 1955-11-15 | |||
| US4666903A (en) * | 1985-08-13 | 1987-05-19 | Yale University | Novel use of benzodiazepine antagonist |
| FR2654621B1 (fr) | 1989-11-22 | 1994-09-23 | Esteve Labor Dr | Inhibition du syndrome d'abstinence. |
| CA2112487C (en) * | 1991-06-26 | 2003-04-15 | James W. Young | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| IL123716A (en) * | 1997-03-27 | 2001-03-19 | Akzo Nobel Nv | Therapeutic combinations of mirtazapine and an antipsychotic agent |
| JP2001517223A (ja) | 1997-04-02 | 2001-10-02 | バイオニケ ライフ サイエンシーズ インコーポレイテッド | 原生動物性または寄生生物性疾患の予防、治療または排除のための細菌細胞壁抽出物の使用 |
-
1999
- 1999-08-13 FR FR9910472A patent/FR2797399B1/fr not_active Expired - Fee Related
-
2000
- 2000-07-28 ES ES00956565T patent/ES2214305T3/es not_active Expired - Lifetime
- 2000-07-28 JP JP2001516607A patent/JP5078209B2/ja not_active Expired - Fee Related
- 2000-07-28 EP EP00956565A patent/EP1212119B1/fr not_active Expired - Lifetime
- 2000-07-28 PT PT00956565T patent/PT1212119E/pt unknown
- 2000-07-28 CA CA002381354A patent/CA2381354C/en not_active Expired - Lifetime
- 2000-07-28 DK DK00956565T patent/DK1212119T3/da active
- 2000-07-28 AT AT00956565T patent/ATE262362T1/de active
- 2000-07-28 AU AU68463/00A patent/AU6846300A/en not_active Abandoned
- 2000-07-28 WO PCT/FR2000/002186 patent/WO2001012265A1/fr active Search and Examination
- 2000-07-28 DE DE60009315T patent/DE60009315T2/de not_active Expired - Lifetime
-
2002
- 2002-02-11 US US10/073,436 patent/US6534500B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2214305T3 (es) | 2004-09-16 |
| US6534500B2 (en) | 2003-03-18 |
| DE60009315D1 (de) | 2004-05-13 |
| WO2001012265A1 (fr) | 2001-02-22 |
| JP2003507352A (ja) | 2003-02-25 |
| CA2381354A1 (fr) | 2001-02-22 |
| CA2381354C (en) | 2008-12-30 |
| AU6846300A (en) | 2001-03-13 |
| JP5078209B2 (ja) | 2012-11-21 |
| FR2797399A1 (fr) | 2001-02-16 |
| US20020183332A1 (en) | 2002-12-05 |
| DK1212119T3 (da) | 2004-06-21 |
| EP1212119A1 (fr) | 2002-06-12 |
| FR2797399B1 (fr) | 2002-10-18 |
| ATE262362T1 (de) | 2004-04-15 |
| DE60009315T2 (de) | 2005-02-17 |
| EP1212119B1 (fr) | 2004-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1143967E (pt) | Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas | |
| RS50091B (sr) | Upotreba retigabina u lečenju neuropatskog bola | |
| BR9710994A (pt) | Derivados anticonvulsivos úteis no tratamento de obesidade. | |
| MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
| HK1051690A1 (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain. | |
| BR0012568A (pt) | Inibidores do transporte de fosfato | |
| SE9802208D0 (sv) | Novel compounds | |
| MY124786A (en) | Bis-arylsulfones | |
| ZA987140B (en) | Treatment of attention deficit disorders | |
| DK0946157T3 (da) | Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte | |
| ATE316084T1 (de) | Substituierte diazepan | |
| ATE319473T1 (de) | Melagatran zur behandlung von entzündungen | |
| PT1212119E (pt) | Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas | |
| HK1051692A1 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain. | |
| PT1000046E (pt) | Derivados de piperazina activos no trato urinario inferior | |
| PT1152756E (pt) | Derivados de anticonvulsivo uteis no tratamento do autismo | |
| EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
| SE9802209D0 (sv) | Novel compounds | |
| MXPA02007903A (es) | Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres. | |
| CY1108053T1 (el) | Ενωση της κυαμεμαζινης και ενος ατυπου νευροληπτικου | |
| HK1047108A1 (en) | Novel fluoroalkylsubstituted cyclotrisiloxanes, their use for preparation of new polymers and novel polymers. | |
| HK1046143A1 (en) | Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa | |
| BR9914722A (pt) | Derivados de anticonvulsivo úteis no tratamento de dependência, vìcio e abuso do álcool | |
| IL139144A0 (en) | Mycobacterial inhibitors | |
| ZA200201384B (en) | 1,4-dioxacycloalkane-2-one and 1,4-dioxacyloalkene-2-one. |